A promising ultrasound therapy to potentially restore brain function in people with Alzheimer’s disease has been licenced to a new start-up spun out of The University of Queensland.
J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice
Dive Brief: The Food and Drug Administration has categorized an urgent medical device correction from Johnson & Johnson’s Megadyne as a Class I event. Megadyne